Trailing-twelve-month (TTM) revenue is $2.44 Billion with a year-over-year growth of +6.62%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q4 FY2025Period ended 2025-08-31 | $596,901,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-22 |
| Q1 FY2026Period ended 2025-11-30 | $607,621,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-01-05 |
| Q2 FY2026Period ended 2026-02-28 | $611,019,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-02 |
| Q3 FY2026Period ended 2026-05-31 | $622,918,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-07-01 |
| TTM revenue | $2,438,459,000 |
Current P/S: $10,094,568,070 market capitalization ÷ $2,438,459,000 TTM revenue = 4.14x.
Market capitalization source: FMP quote. Quote observed 2026-09-18T20:00:03.000Z. Latest revenue period ended 2026-05-31.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q3 FY2026 (2026-05-31): $622.92M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-19T00:15:38.498Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-08-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-08-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20112011-08-31 · USD | FY20222022-08-31 · USD | FY20232023-08-31 · USD | FY20242024-08-31 · USD | FY20252025-08-31 · USD |
|---|---|---|---|---|---|
| Americas Segment | $498M | $1.2B | $1.3B | $1.4B | $1.5B |
| Asia Pacific Segment | $50M | $186M | $210M | $220M | $235M |
| EMEA Segment |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-08-31 · USD | FY20212021-08-31 · USD | FY20222022-08-31 · USD | FY20232023-08-31 · USD | FY20242024-08-31 · USD | FY20252025-08-31 · USD |
|---|---|---|---|---|---|---|
| Americas Segment | $929M | N/A | N/A | N/A | N/A | N/A |
| Asia Pacific | $142M | N/A |
$2.44B
$2.44 Billion
+6.62%
vs. $2.29B a year ago (TTM)
+9.30%
5 Year compound annual growth rate
1 Year
+6.62%
3 Year
+5.97%
5 Year
+9.30%
10 Year
+8.27%
15 Year
+8.65%
20 Year
+9.96%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $2.32B | +$118.69M | +5.39% |
| 2024 | $2.20B | +$117.55M | +5.64% |
| 2023 | $2.09B | +$241.62M | +13.10% |
| 2022 | $1.84B | +$252.45M | +15.86% |
| 2021 | $1.59B | +$97.33M | +6.51% |
| 2020 |
TTM Growth
+6.62%
3-Year CAGR
+5.97%
5-Year CAGR
+9.30%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $179M |
| $484M |
| $540M |
| $563M |
| $580M |
| N/A |
| N/A |
| N/A |
| Europe | $422M | $238M | $269M | $316M | $341M | $349M |
|---|
| UNITED KINGDOM | N/A | $190M | $215M | $224M | $222M | $231M |
|---|
| UNITED STATES | $885M | $952M | $1.1B | $1.3B | $1.3B | $1.4B |
|---|
| $1.49B |
| +$58.76M |
| +4.09% |
| 2019 | $1.44B | +$85.21M | +6.31% |
| 2018 | $1.35B | +$128.97M | +10.56% |
| 2017 | $1.22B | +$94.09M | +8.35% |
| 2016 | $1.13B | +$120.32M | +11.95% |
